NASA wants to make a nasal spray that stops motion sickness
NASA has done a lot in its day—from putting a man on the Moon to exploring the surface of Mars. What you might not know is that some of the technology pioneered by the space agency continues to help up today (and we're not just talking about Tang). Now the space agency hopes to bring another of its bold inventions to the masses to help treat motion sickness.
NASA is developing a nasal spray version of scopolamine, a drug used to treat motion sickness. If scopalamine sounds familiar to you, that’s because scuba divers already use it in tablet form to help with seasickness.
Astronauts, of course, have to deal with some of the most extreme gravitational forces felt by anyone when they ride on a rocket to space. After extensive testing, scientists at NASA's Johnson Space Center found that an Intranasal Scopalamine spray (INSCOP) works faster and more reliably than any pill.
According to Geek.com, NASA has signed an agreement with Epiomed Therapeutics to develop and commercialize INSCOP. The two companies first conduct clinical trials of their motion sickness nasal spray to get the FDA’s approval. Hopefully the drug will come to market soon to help everyone on a plane or boat.